FilingsTodayCardinal Health
At a glance
Cardinal Health reported 2025 revenue of $222.58B, down 1.9% from $226.83B in 2024. Over 4 years since 2021 ($162.47B), that is growth of about 8.2% a year. Operating margin was 1%, up from 0.3% in 2021. Revenue peaked in 2024 at $226.83B. The company posted a loss in 2022.
In the last 12 months 8 insiders reported 0 open-market purchases and 10 sales ($61.6M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $29.4M by Chief Executive Officer Jason M. Hollar on Aug 20, 2026.
Cardinal Health filed 10 current reports (Form 8-K) in the last 12 months, most often for results of operations (3), officer or director change (3), regulation fd disclosure (2) and material agreement (1). The latest officer or director change was reported on Aug 5, 2026. It reported a material agreement or a completed acquisition or disposal 1 time.
3 of the 20 investors tracked here held Cardinal Health at the last quarter end, worth $275.5M combined. It is the largest weight for Renaissance Technologies (0.2% of its portfolio), followed by Bridgewater Associates (0.1%). Added: Renaissance Technologies, Bridgewater Associates and National Pension Service (Korea).
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $611M | -$938M | $330M | $852M | $1.56B |
| Diluted EPS | $2.08 | $-3.37 | $1.26 | $3.45 | $6.45 |
| Dividend per share | $1.94 | $1.96 | $1.98 | $2.00 | $2.02 |
Fiscal year ends Jun 30 · incorporated in OH
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined